private:therasis
|
641128
|
Jun 4th, 2019 12:00AM
|
Therasis Inc.
|
32
|
1.00
|
Open
|
Biotechnology
|
Jun 3rd, 2019 09:33PM
|
Jun 3rd, 2019 09:33PM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
Open
|
|
|
|
|
|
US
|
10016
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Mar 23rd, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Mar 23rd, 2017 10:51AM
|
Mar 23rd, 2017 10:51AM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Feb 17th, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Feb 16th, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Feb 15th, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Feb 14th, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Feb 13th, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Feb 12th, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Feb 11th, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|
private:therasis
|
641128
|
Feb 10th, 2018 12:00AM
|
Therasis Inc.
|
30
|
1.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Therasis Inc. is a new drug discovery company developing oncology therapeutics for use as single agents or in combination therapy. The Company’s proprietary technology, the Therasis Filter™, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers. This platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. Therasis plans to leverage its discovery engine to identify new chemical entities for internal development and to forge collaborations with pharmaceutical and biotechnology companies on drug repositioning.
|
|
|
|
|
|
|
|
|
|
Therasis
|
|
Health Care Equipment & Services
|